DEXTROAMPHETAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dextroamphetamine, and when can generic versions of Dextroamphetamine launch?
Dextroamphetamine is a drug marketed by Able, Actavis Elizabeth, Nesher Pharms, Quagen, Senores Pharms, Specgx Llc, Strides Pharma, Strides Pharma Intl, Prasco, Tris Pharma Inc, Ani Pharms, Aurolife Pharma Llc, Avanthi Inc, Azurity, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vitarine, and Winder Labs Llc. and is included in thirty-three NDAs.
The generic ingredient in DEXTROAMPHETAMINE is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dextroamphetamine
A generic version of DEXTROAMPHETAMINE was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEXTROAMPHETAMINE?
- What are the global sales for DEXTROAMPHETAMINE?
- What is Average Wholesale Price for DEXTROAMPHETAMINE?
Summary for DEXTROAMPHETAMINE
| US Patents: | 0 |
| Applicants: | 25 |
| NDAs: | 33 |
| Drug Prices: | Drug price information for DEXTROAMPHETAMINE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DEXTROAMPHETAMINE |
| DailyMed Link: | DEXTROAMPHETAMINE at DailyMed |
Recent Clinical Trials for DEXTROAMPHETAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Eva Szigethy | Phase 4 |
| The Beckwith Institute | Phase 4 |
| Vallon Pharmaceuticals, Inc. | Phase 1 |
US Patents and Regulatory Information for DEXTROAMPHETAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090652-001 | Mar 7, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Azurity | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090533-001 | Oct 25, 2011 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Nesher Pharms | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 206588-001 | Mar 28, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma Intl | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 040299-001 | May 13, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
